市場調査レポート

商品コード

1596908

臨床栄養の市場規模、シェア、成長分析、投与経路別、用途別、流通チャネル別、エンドユーザー別、地域別 - 産業予測、2024年～2031年

Clinical Nutrition Market Size, Share, Growth Analysis, By Route of Administration (Oral, Parenteral) By Application (Cancer, Neurological Diseases), By Distribution Channel, By End User, By Region - Industry Forecast 2024-2031

出版日: 2024年11月21日
発行: SkyQuest
ページ情報: 英文 165 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 767,811円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 898,194円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,028,577円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.87円

全表示
概要
目次

概要

サンプル依頼リストに入れる

臨床栄養の世界市場規模は、2022年に356億米ドルと評価され、2023年の387億米ドルから2031年には711億米ドルに成長し、予測期間中（2024-2031年）のCAGRは7.9％で成長する見通しです。

臨床栄養市場は、糖尿病や炎症性腸疾患などの生活習慣病有病率の増加により、オーダーメイドの栄養サポートの必要性が浮き彫りになり、大きな成長が見込まれています。臨床栄養は、患者の健康増進を目的とした必須ビタミン、ミネラル、栄養素による代謝システムの最適化に焦点を当てています。その用途は、心臓リハビリテーション、腎透析、小児栄養、がんサポート、外傷回復、ウェルネスイニシアチブなど様々な分野に及び、ヘルスケアにおけるその汎用性を裏付けています。高齢化社会とヘルスケア研究開発への政府投資は市場拡大をさらに後押しします。さらに、アジア太平洋やラテンアメリカなどの新興地域における臨床栄養の需要の高まりと、在宅ヘルスケアソリューションへの傾向の高まりは、世界の臨床栄養市場を予測期間中の魅力的な投資機会として位置づけています。ヘルスケアが進化し続ける中、臨床栄養を治療計画や予防ケア戦略に組み込むことは、健康アウトカムを改善し、多様な人々の栄養ニーズに対応する上で重要な役割を果たすでしょう。

北米
- 米国
- カナダ
欧州
- 英国
- ドイツ
- スペイン
- フランス
- イタリア
- その他欧州地域
アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東およびアフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ

競合情報

上位5社の比較
主要企業の市場ポジショニング（2023年）
主な市場企業が採用した戦略
市場の最近の動向
企業の市場シェア分析（2023年）
主要企業の企業プロファイル
- 会社概要
- 製品ポートフォリオ分析
- セグメント別シェア分析
- 収益の前年比比較（2021-2023）

主要企業プロファイル

Abbott Laboratories（U.S.）
Nestle Health Science（Switzerland）
Danone Nutricia（France）
Fresenius Kabi（Germany）
Baxter International（U.S.）
B. Braun Melsungen AG（Germany）
Mead Johnson Nutrition（Reckitt）（U.S.）
GlaxoSmithKline（GSK）（U.K.）
Pfizer（U.S.）
Ajinomoto Co., Inc.（Japan）
Koninklijke DSM N.V.（Netherlands）
Lonza Group（Switzerland）
Cambrooke Therapeutics（U.S.）
Sichuan Kelun Pharmaceutical Co. Ltd.（China）
Otsuka Pharmaceutical（Japan）
Hormel Health Labs（U.S.）
Perrigo Company（Ireland）
Hero Group（Switzerland）
Victus（U.S.）
Entrocare Nutritional Solutions（U.K.）

結論と推奨事項

Product Code: SQMIG30A2012

Global Clinical Nutrition Market size was valued at USD 35.6 billion in 2022 and is poised to grow from USD 38.7 billion in 2023 to USD 71.1 billion by 2031, growing at a CAGR of 7.9% during the forecast period (2024-2031).

The clinical nutrition market is poised for significant growth, driven by the increasing prevalence of lifestyle-related diseases such as diabetes and inflammatory bowel disease, which highlight the need for tailored nutritional support. Clinical nutrition focuses on optimizing the metabolic system through essential vitamins, minerals, and nutrients aimed at enhancing patient health. Its applications span various sectors, including cardiac rehabilitation, renal dialysis, pediatric nutrition, cancer support, trauma recovery, and wellness initiatives, underpinning its versatility in healthcare. The aging population and substantial government investments in healthcare research and development further bolster market expansion. Additionally, the rising demand for clinical nutrition in emerging regions such as Asia-Pacific and Latin America, coupled with a growing trend towards home healthcare solutions, positions the global clinical nutrition market as an attractive investment opportunity during the forecast period. As healthcare continues to evolve, the integration of clinical nutrition into treatment plans and preventive care strategies will play a crucial role in improving health outcomes and addressing the nutritional needs of diverse populations.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Clinical Nutrition market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Clinical Nutrition Market Segmental Analysis

Global Clinical Nutrition Market is segmented by Route of Administration, application, Distribution Channel, end user, Nutritional Content and region. Based on Route of Administration, the market is segmented into Oral, Parenteral, and Enteral. Based on Application, the market is segmented into Cancer, Neurological Diseases, Gastrointestinal Disorder, Metabolic Disorder, and Others. Based on Distribution Channel, the market is segmented into Online and Offline. Based on end user, the market is segmented into Paediatric, Adults, and Geriatric. Based on By Nutritional Content, the market is segmented into Protein-Based Nutrition, Vitamin and Mineral-Rich Nutrition, Carbohydrate-Based Nutrition, and Fat-Based Nutrition. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Clinical Nutrition Market

The global clinical nutrition market is experiencing significant growth due to the increasing prevalence of lifestyle-related diseases and the rising elderly population. As individuals age, their activity levels diminish, metabolic rates decrease, and energy needs decline, leading to a deterioration in their ability to absorb and utilize essential nutrients. This decline amplifies their nutritional requirements, creating a heightened demand for clinical nutrition solutions that enhance energy absorption and utilization. Consequently, the growing emphasis on meeting the specific nutritional needs of older adults is poised to drive market expansion throughout the forecast period, reflecting a broader trend towards proactive health management.

Restraints in the Global Clinical Nutrition Market

The Global Clinical Nutrition market faces significant challenges, primarily due to a lack of awareness and the high costs associated with clinical nutrition products. Despite a rising demand for therapeutic nutritional solutions, both healthcare professionals and the general public remain largely uninformed about the benefits of clinical nutrition in both developed and developing nations. This limited understanding has contributed to widespread misinformation regarding vitamins and dietary practices, leading to nutritional deficiencies and related health issues. Consequently, the inadequate knowledge and appreciation of clinical nutrition serve as substantial barriers to market growth, hindering its expansion throughout the forecast period.

Market Trends of the Global Clinical Nutrition Market

The Global Clinical Nutrition market is witnessing significant growth fueled by enhanced healthcare infrastructure and a rising necessity for improved healthcare solutions, particularly in emerging regions like Asia-Pacific and LAMEA. This trend is further accelerated by the alarming rise in lifestyle-related chronic diseases that contribute to malnutrition and dietary complications. As healthcare demands evolve, there is an increased emphasis on research and development of specialized medical devices aimed at addressing diverse health issues, including respiratory, renal, and oncological conditions. Consequently, these factors are creating lucrative opportunities for expansion and innovation within the clinical nutrition sector.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Driver & Opportunities
- Restraints & Challenges
Porters Analysis & Impact
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Regulatory Landscape
Patent Analysis
Value Chain Analysis
PESTEL Analysis
Market Attractiveness Index
Raw Material Analysis
Pricing Analysis

Global Clinical Nutrition Market Size by Route of Administration & CAGR (2024-2031)

Market Overview
Oral
Parenteral
Enteral

Global Clinical Nutrition Market Size by Application & CAGR (2024-2031)

Market Overview
Cancer
Neurological Diseases
Gastrointestinal Disorder
Metabolic Disorder
Others

Global Clinical Nutrition Market Size by Distribution Channel & CAGR (2024-2031)

Market Overview
Online
Offline
- Retail Stores
- Institutional Sales Channel
- Others

Global Clinical Nutrition Market Size by End User & CAGR (2024-2031)

Market Overview
Pediatrics
Adults
Geriatric

Global Clinical Nutrition Market Size by Nutritional Content & CAGR (2024-2031)

Market Overview
Protein-Based Nutrition
Vitamin and Mineral-Rich Nutrition
Carbohydrate-Based Nutrition
Fat-Based Nutrition

Global Clinical Nutrition Market Size & CAGR (2024-2031)

North America, (By Route of Administration, By Application, By Distribution Channel, By End User, By Nutritional Content)
- US
- Canada
Europe, (By Route of Administration, By Application, By Distribution Channel, By End User, By Nutritional Content)
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific, (By Route of Administration, By Application, By Distribution Channel, By End User, By Nutritional Content)
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
Latin America, (By Route of Administration, By Application, By Distribution Channel, By End User, By Nutritional Content)
- Brazil
- Rest of Latin America
Middle East & Africa, (By Route of Administration, By Application, By Distribution Channel, By End User, By Nutritional Content)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2023
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Abbott Laboratories (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nestle Health Science (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danone Nutricia (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fresenius Kabi (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Baxter International (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
B. Braun Melsungen AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mead Johnson Nutrition (Reckitt) (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GlaxoSmithKline (GSK) (U.K.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ajinomoto Co., Inc. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Koninklijke DSM N.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lonza Group (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cambrooke Therapeutics (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sichuan Kelun Pharmaceutical Co. Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Otsuka Pharmaceutical (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hormel Health Labs (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Perrigo Company (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hero Group (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Victus (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Entrocare Nutritional Solutions (U.K.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

臨床栄養の市場規模、シェア、成長分析、投与経路別、用途別、流通チャネル別、エンドユーザー別、地域別 - 産業予測、2024年～2031年

Clinical Nutrition Market Size, Share, Growth Analysis, By Route of Administration (Oral, Parenteral) By Application (Cancer, Neurological Diseases), By Distribution Channel, By End User, By Region - Industry Forecast 2024-2031

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主な市場の考察

臨床栄養の市場規模：投与経路別

臨床栄養の市場規模：用途別

臨床栄養の市場規模：流通チャネル別

臨床栄養の市場規模：エンドユーザー別

臨床栄養の市場規模：栄養成分別

臨床栄養の市場規模：地域別